The derivative of lysergic acid for migraine attack prevention is:

Questions 52

ATI RN

ATI RN Test Bank

Pharmacology of Cardiovascular Drugs Questions

Question 1 of 5

The derivative of lysergic acid for migraine attack prevention is:

Correct Answer: B

Rationale: In the context of pharmacology, understanding the rationale behind why a specific drug is the correct answer is crucial for students' comprehension. In this case, the correct answer is B) Methysergide. Methysergide is a derivative of lysergic acid and is used for the prevention of migraine attacks. This drug works by blocking serotonin receptors, which are implicated in the pathophysiology of migraines. Now, let's delve into why the other options are incorrect: A) Metoclopramide: Metoclopramide is a prokinetic agent that acts on dopamine receptors in the gastrointestinal tract. It is not indicated for migraine prevention and is not a derivative of lysergic acid. C) Sumatriptan: Sumatriptan is a selective serotonin receptor agonist used to treat acute migraine attacks, not for prevention. It does not belong to the lysergic acid derivative group. D) Ergotamine: Ergotamine is also used for treating acute migraine attacks, not prevention. While it is derived from ergot alkaloids, it is not a derivative of lysergic acid like Methysergide. Educationally, understanding the specific pharmacological properties of each drug and their intended uses is essential for healthcare professionals to make informed decisions when treating patients. Knowing the mechanisms of action and indications of drugs can help prevent medication errors and ensure optimal patient outcomes.

Question 2 of 5

Which of the following statements concerning the anti-inflammatory effect of NSAIDs are TRUE?

Correct Answer: A

Rationale: In pharmacology, understanding the mechanism of action of drugs is crucial for effective application. In the context of NSAIDs and their anti-inflammatory effects, option A is correct because the primary mechanism of action of NSAIDs is the inhibition of cyclooxygenase (COX) enzymes, specifically COX-1 and COX-2, thereby reducing the production of prostaglandins involved in the inflammatory response. Option B is incorrect as NSAIDs do not primarily act by inhibiting phospholipase A2; instead, they target the COX enzymes. Prostaglandins and leukotrienes are indeed involved in inflammation, but NSAIDs act further downstream in their synthesis. Option C is also incorrect. NSAIDs do not induce the expression of COX-2 to reduce enzyme availability for prostaglandin production. In fact, NSAIDs inhibit COX-2 along with COX-1. Educationally, this question highlights the importance of understanding the specific mechanisms of action of drugs to predict their effects accurately. Knowing that NSAIDs exert their anti-inflammatory effects through COX inhibition helps in rational prescribing and managing potential side effects associated with these drugs.

Question 3 of 5

Immunosuppressive drug is any of a variety of substances used to prevent production of antibodies, protein produced by the immune system in response to the presence in the body of antigens: foreign proteins or polysaccharides such as bacteria, bacterial toxins, viruses, or other cells or proteins. This consideration is:

Correct Answer: A

Rationale: The correct answer is A) TRUE. In the context of pharmacology, immunosuppressive drugs are indeed substances used to prevent the production of antibodies. This is crucial in various medical scenarios, such as organ transplantation, autoimmune diseases, and to prevent rejection in grafts. By suppressing the immune response and antibody production, these drugs help in managing conditions where the immune system attacks the body's own tissues. Option B) FALSE is incorrect because immunosuppressive drugs are specifically designed to inhibit the immune system's response, including the production of antibodies. Option C) All and D) None are also incorrect as they do not accurately reflect the targeted action of immunosuppressive drugs. In an educational context, understanding the mechanism of action of immunosuppressive drugs is fundamental in pharmacology, especially in the treatment of conditions where immune system activity needs to be modulated. This knowledge is essential for healthcare professionals to make informed decisions regarding drug therapy, potential side effects, and patient care.

Question 4 of 5

Which of the following statements concerning pyridoxine (vitamin B6) functions are true:

Correct Answer: A

Rationale: In the context of pharmacology, understanding the functions of pyridoxine (vitamin B6) is crucial as it plays a significant role in various physiological processes. The correct statement, option A, is true because pyridoxal phosphate is indeed the active functional form of vitamin B6, serving as a vital coenzyme in over 50 enzyme systems involved in amino acid metabolism through transamination and decarboxylation. This is essential for the synthesis of neurotransmitters, heme, and nucleic acids. Option B is incorrect as the active groups of the coenzymes NAD and NADP are derived from niacin (vitamin B3) and not pyridoxine. Option C is also incorrect as flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD) are derived from riboflavin (vitamin B2) and not pyridoxine. Option D is incorrect as pyridoxine is not primarily known for its antioxidant properties; its main functions are related to amino acid metabolism. Educationally, knowing the specific functions of vitamins, including pyridoxine, is essential for understanding their roles in various biochemical pathways and how deficiencies or excesses can impact health. This knowledge is particularly relevant in pharmacology when considering drug interactions, side effects, and therapeutic uses of medications that may affect vitamin B6 metabolism.

Question 5 of 5

Agents, which lower levels of LDL-cholesterol, tend to promote regression of atherosclerotic plaques. This consideration is:

Correct Answer: A

Rationale: In pharmacology, agents that lower levels of LDL-cholesterol indeed tend to promote regression of atherosclerotic plaques. This is because LDL-cholesterol is a major contributor to the development and progression of atherosclerosis, a condition characterized by the buildup of plaques in the arteries. By reducing LDL-cholesterol levels, these agents help slow down or even reverse the accumulation of plaques, leading to regression of atherosclerosis. Option A (TRUE) is correct because it aligns with the established pharmacological principles of managing atherosclerosis by targeting LDL-cholesterol levels. Lowering LDL-cholesterol is a key strategy in the treatment and prevention of atherosclerotic cardiovascular disease. Options B, C, and D are incorrect because they do not acknowledge the relationship between LDL-cholesterol levels and atherosclerosis regression. Choosing any of these options would imply a misunderstanding of the pharmacological mechanisms involved in managing cardiovascular health. From an educational perspective, understanding the role of LDL-cholesterol in atherosclerosis and the impact of pharmacological agents on plaque regression is crucial for healthcare professionals, especially those involved in cardiovascular care. This knowledge helps in making informed decisions about treatment strategies and optimizing patient outcomes in the management of cardiovascular diseases.

Access More Questions!

ATI RN Basic


$89/ 30 days

ATI RN Premium


$150/ 90 days

Similar Questions